BENZONATATE CAPSULES

Benzonatate Capsules, USP, 100 mg, are supplied in bottles of 100 capsules each, with the active ingredient being 100 milligrams of benzonatate per capsule. The product must be stored at controlled room temperature between 20° to 25°C (68° to 77°F) and protected from light, moisture, and humidity. It is regulated by the FDA and classified as a TYPE I (CODE Q) item with a non-extendable shelf life of 36 months. Packaging must comply with the latest edition of the Medical Marking Standard No. 1 and meet MIL-STD-2073-1E requirements for preparation for delivery. The item is identified by NSN 6505-00-660-1798 and NDC numbers for approved manufacturers including AVKARE LLC, GOLDEN STATE MEDICAL SUPPLY, INC., and PROFICIENT RX LP. The solicitation, issued under contract number SPE2DP-26-T-4028, requires delivery within five days to Fort Stewart, Georgia, with FOB destination terms and no variance allowed in quantity. Inspection and acceptance occur at the delivery point. The contract incorporates technical and quality requirements from the DLA Master List of Technical and Quality Requirements, and all packaging must adhere to DLA packaging standards. Government identification must be removed from non-accepted supplies. The solicitation was posted on July 6, 2026, with a response deadline of July 13, 2026, and is managed by the Department of Defense’s Medical Supply Chain PHARM FSA office, with Imerah Burnett as the primary point of contact. The NAICS code is 325412, and the unit of issue is a bottle of 100 capsules.